IN2015DN01331A - - Google Patents
Info
- Publication number
- IN2015DN01331A IN2015DN01331A IN1331DEN2015A IN2015DN01331A IN 2015DN01331 A IN2015DN01331 A IN 2015DN01331A IN 1331DEN2015 A IN1331DEN2015 A IN 1331DEN2015A IN 2015DN01331 A IN2015DN01331 A IN 2015DN01331A
- Authority
- IN
- India
- Prior art keywords
- trifluoromethylpyridin
- morpholinyl
- pyrimidinyl
- intermediates
- amine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261717237P | 2012-10-23 | 2012-10-23 | |
| US201361842101P | 2013-07-02 | 2013-07-02 | |
| PCT/EP2013/071996 WO2014064058A1 (fr) | 2012-10-23 | 2013-10-21 | Procédé amélioré pour la fabrication de 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluorométhylpyridin-2-amine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01331A true IN2015DN01331A (fr) | 2015-07-03 |
Family
ID=49448162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1331DEN2015 IN2015DN01331A (fr) | 2012-10-23 | 2013-10-21 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9637468B2 (fr) |
| EP (1) | EP2912030B1 (fr) |
| JP (1) | JP6267213B2 (fr) |
| KR (1) | KR102128127B1 (fr) |
| CN (1) | CN104736532B (fr) |
| AU (2) | AU2013336807B2 (fr) |
| BR (1) | BR112015007243B1 (fr) |
| CA (1) | CA2885471C (fr) |
| ES (1) | ES2605638T3 (fr) |
| IN (1) | IN2015DN01331A (fr) |
| MX (1) | MX360703B (fr) |
| PL (1) | PL2912030T3 (fr) |
| PT (1) | PT2912030T (fr) |
| RU (1) | RU2646760C2 (fr) |
| WO (1) | WO2014064058A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014007310A2 (pt) | 2011-09-27 | 2017-04-04 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante |
| UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
| US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
| WO2014110466A1 (fr) * | 2013-01-12 | 2014-07-17 | Dawei Zhang | Composés pyridine utilisés en tant qu'inhibiteurs de pi3 kinase |
| EP2970240B1 (fr) | 2013-03-14 | 2018-01-10 | Novartis AG | 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante |
| EP3134388B1 (fr) | 2014-04-22 | 2019-01-09 | Universität Basel | Nouveau procédé de fabrication de dérivés de triazine, pyrimidine et pyridine |
| CN107001317B (zh) * | 2014-09-29 | 2019-05-24 | 山东轩竹医药科技有限公司 | 高选择性取代嘧啶类pi3k抑制剂 |
| CN105085476B (zh) * | 2014-11-24 | 2018-03-09 | 苏州晶云药物科技有限公司 | 5‑[2,6‑二(4‑吗啉基)‑4‑嘧啶基]‑4‑(三氟甲基)‑2‑吡啶胺二盐酸盐的晶型及其制备方法 |
| CN105001151B (zh) * | 2015-08-28 | 2017-07-14 | 苏州明锐医药科技有限公司 | 布帕尼西中间体及其制备方法 |
| CN106543140A (zh) * | 2015-09-21 | 2017-03-29 | 苏州晶云药物科技有限公司 | 5-[2,6-二(4-吗啉基)-4-嘧啶基]-4-(三氟甲基)-2-吡啶胺盐酸盐的晶型及其制备方法 |
| CN107793394A (zh) * | 2017-08-03 | 2018-03-13 | 上海厚璞生物科技有限公司 | 一种生产选择性pi3k抑制剂的系列关键中间体 |
| US20220056027A1 (en) * | 2018-12-18 | 2022-02-24 | Astrazeneca Ab | Pharmaceutical process and intermediates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4061194B2 (ja) * | 2001-02-08 | 2008-03-12 | 富山化学工業株式会社 | ６−置換アルキルアミノ−３−ピリジルホウ酸誘導体またはその塩およびそれらの製造法 |
| MXPA05005477A (es) * | 2002-11-21 | 2005-07-25 | Chiron Corp | Pirimidinas 2,4,6-trisustituidas como inhibidores de fosfotidilinositol (pi) 3-cinasa y su uso en el tratamiento del cancer. |
| JO2660B1 (en) * | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| MX354482B (es) * | 2010-10-01 | 2018-03-07 | Novartis Ag Star | Proceso de elaboración para derivados de pirimidina. |
-
2013
- 2013-10-21 BR BR112015007243-7A patent/BR112015007243B1/pt active IP Right Grant
- 2013-10-21 CN CN201380055482.4A patent/CN104736532B/zh active Active
- 2013-10-21 RU RU2015119259A patent/RU2646760C2/ru active
- 2013-10-21 EP EP13779841.9A patent/EP2912030B1/fr active Active
- 2013-10-21 US US14/437,177 patent/US9637468B2/en active Active
- 2013-10-21 MX MX2015005188A patent/MX360703B/es active IP Right Grant
- 2013-10-21 AU AU2013336807A patent/AU2013336807B2/en active Active
- 2013-10-21 PT PT137798419T patent/PT2912030T/pt unknown
- 2013-10-21 CA CA2885471A patent/CA2885471C/fr active Active
- 2013-10-21 ES ES13779841.9T patent/ES2605638T3/es active Active
- 2013-10-21 JP JP2015538398A patent/JP6267213B2/ja active Active
- 2013-10-21 PL PL13779841T patent/PL2912030T3/pl unknown
- 2013-10-21 WO PCT/EP2013/071996 patent/WO2014064058A1/fr active Application Filing
- 2013-10-21 KR KR1020157010087A patent/KR102128127B1/ko active IP Right Grant
- 2013-10-21 IN IN1331DEN2015 patent/IN2015DN01331A/en unknown
-
2016
- 2016-10-07 AU AU2016238941A patent/AU2016238941A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015119259A (ru) | 2016-12-20 |
| AU2013336807B2 (en) | 2016-10-27 |
| BR112015007243A2 (pt) | 2017-07-04 |
| MX360703B (es) | 2018-11-14 |
| KR20150072408A (ko) | 2015-06-29 |
| CA2885471A1 (fr) | 2014-05-01 |
| JP6267213B2 (ja) | 2018-01-24 |
| KR102128127B1 (ko) | 2020-06-30 |
| PT2912030T (pt) | 2016-11-30 |
| RU2646760C2 (ru) | 2018-03-07 |
| WO2014064058A1 (fr) | 2014-05-01 |
| BR112015007243B1 (pt) | 2022-02-08 |
| CA2885471C (fr) | 2021-02-23 |
| MX2015005188A (es) | 2015-09-07 |
| US9637468B2 (en) | 2017-05-02 |
| PL2912030T3 (pl) | 2017-02-28 |
| AU2013336807A1 (en) | 2015-03-05 |
| EP2912030A1 (fr) | 2015-09-02 |
| EP2912030B1 (fr) | 2016-08-31 |
| US20150246897A1 (en) | 2015-09-03 |
| ES2605638T3 (es) | 2017-03-15 |
| JP2016502510A (ja) | 2016-01-28 |
| AU2016238941A1 (en) | 2016-11-03 |
| CN104736532B (zh) | 2017-04-05 |
| CN104736532A (zh) | 2015-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01331A (fr) | ||
| HUS2300043I1 (hu) | 3,5-diszubsztituált alkilbenzol vegyületek és sóik | |
| HK1217484A1 (zh) | 取代的 -二甲基異噁唑- -基 二氫吲哚- -酮類衍生物 | |
| SG11201912770SA (en) | a, ß-UNSATURATED AMIDE COMPOUND | |
| IN2014DN06812A (fr) | ||
| MX361499B (es) | Baricitinib deuterado. | |
| MY163187A (en) | Novel imidazo-oxazine compound or salt thereof | |
| BR112015001201A2 (pt) | compostos anti-infecciosos 5,5-heteroaromáticos. | |
| IN2015DN00598A (fr) | ||
| HK1258053A1 (zh) | 作為蛋白激酶抑制劑的新的2，3，5-取代的噻吩化合物 | |
| IL231468A0 (en) | 3,1-diaryl-converted heterocyclic pesticides | |
| MX366983B (es) | Derivados de 1,5-naftiridina e inhibidores de cinasa de cremallallera de leucina embrionica materna que los contienen. | |
| IL251500A (en) | A new compound containing nitrogen or its salt or metallic complex | |
| MX2015008829A (es) | Momelotinib deuterado. | |
| WO2014105777A8 (fr) | Sel de dichlohydrate de cobicistat | |
| MX2016016127A (es) | Formas cristalinas. | |
| MX2020006006A (es) | Polimorfos cristalinos de {(2s,3r)-1-[(2s)-2-{5-[(2r,5r)-1-{3,5-di fluoro-4-[4-(4-fluorofenil)piperidin-1-il]fenil}-5-(6-fluoro-2-{( 2s)-1-[n-(metoxicarbonil)-o-metil-l-treonil]pirrolidin-2-il}-1h-b enzimidazol-5-il)pirrolidin-2-il]-6-fluoro-1h-benzimidazol-2-il}p irrolidin-1-il]-3-metoxi-1-oxobutan-2-il}carbamato de metilo. | |
| IT1403920B1 (it) | Composti fotosensibilizzanti "metal free". | |
| MX2015012610A (es) | Pacritinib deuterizado. | |
| MY174415A (en) | Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof | |
| UA87695U (uk) | Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид, що має інотропну активність | |
| UA88965U (uk) | Сполука 1,3-біс-(2-гидроксіетил)-урацил, що має інотропну активність | |
| WO2015092687A3 (fr) | Processus de purification de darapladib | |
| UA83239U (uk) | 2-(4,5-дифеніл-4h-[1,2,4]триазол-3-їлсульфаніл)-n-арилацетаміди, що мають протипухлинну активність | |
| TH116418B (th) | หน้าตัดโลหะ |